-
Our latest preprint. We made mammalian cells resistant to a variety of viruses by engineering STAT1 mediated innate immunity. This may help safeguard the availability and safety of many biopharmaceuticals.
@pharminews#Biopharm https://twitter.com/biorxivpreprint/status/1043069900837793792 … -
We’re on our way to
@APS_PharmSci#PharmSci2019 conference! Looking forward to catching up with colleagues and meeting new inspiring scientists in the#pharmaindustry!#PhD#research#drugdelivery#3Dprinting#biopharm pic.twitter.com/tsK39n1t4O
Prikaži ovu nit -
Paving the way for future technology leaders!
@GSK#GirlsWhoCode#biopharm https://lnkd.in/eCrEMWF -
Continuous processing vs traditional manufacturing? Find out more about our high performance TPE tubing here https://www.watson-marlow.com/us-en/range/tubing/pureweld/ …
#biopharm pic.twitter.com/D6hPOZDgyk
-
Traditional vaccine and antibodies production requires massive labs, but a
#hydroponics farm in Cape Town is changing this.#biopharm#biopharming#CarteBlanchepic.twitter.com/I9uLgXWCAHBiopharmingTraditional vaccine and antibodies production requires massive labs, but a #hydroponics farm in Cape Town is changing this. #biopharm #biopharming #CarteBlanche -
Don't give up one me
#Biopharm -
Peanut-allergy trial holds hope for kids https://buff.ly/2Smbnly
@aimmune#biopharm pic.twitter.com/fULwmlcXig
-
Reaching positive patient expectations is the goal to successful treatment. Continued compliance is critical to this success.
#Hulogix#biopharm#epigeneticspic.twitter.com/J1W6jKTdunOvo je potencijalno osjetljiv multimedijski sadržaj. Saznajte više
-
Just before the ring of the new year, two new billion-dollar acquisitions were set in place. Roche plans to acquire
#biopharm company Ignyta for $1.7 billion; Mallinckrodt plans to acquire biopharm company Sucampo for $1.2 billion. http://ow.ly/yuLY30hzZpS http://ow.ly/ZBHW30hzZso pic.twitter.com/9FQzhdw4Gw
-
Interview by
@aHUSAllianceAct: Dr Ralf Reski of@ReskiLab shares info &#research re Moss-FH, in preclinical stages for C3 Glomerulopathy. Potential#therapeutic#drug for atypical HUS, re Factor H. http://www.ahusallianceaction.org/dr-ralf-reski-moss-made-biopharmaceuticals/ …#C3G#aHUS#biopharm#pharma#biotech@GreenovationDE -
Breathing deeply in moments of stress, or anytime during the day, brings many benefits such as better circulation, decreased anxiety and reduced blood pressure.
#breathe#blood#healthfacts#Biotech#Biopharm#Medicare#Medicaid#Biologics#healthcare#health#pharmaceuitical -
Excited to hear from the speakers at today's
@LifeSciencesPA Life Sciences Future –#BioPharm event!@marksawkapic.twitter.com/hQI06nM6dG
-
Day two
@PPMATotalShow For the#biopharm industry, see our fully automated Flexicon FF30 in action on stand D90. https://www.watson-marlow.com/gb-en/exhibitions/ppma-2019/ …#ukmfg#engineering#PPMATotalShowpic.twitter.com/b1l9eh7GZU -
Just a little insider on @G1Therapeutics' new space at#Frontier700! G1 is a clinical-stage#biopharm company focused on improving the lives of those affected by cancer. pic.twitter.com/enRlauIlCJ
-
Day 1 of induction week. Fantastic to meet the new cohort Welcome to our course and thank you for choosing
@dmuhls as your place of study. Hopefully being joined by the other half of the cohort as the week progresses Enjoy the year and course#pgcourse#Studying#biopharm#MScpic.twitter.com/aaXIkT56G7
-
So proud that
@FinnPartners is the global#PR partners with@GalienFdn advancing#biopharm#med/device innovation to improve human health.https://twitter.com/finnpartners/status/923702731679739904 …
-
Imagine your
#biopharm LC-MS system is ready for its first analytical run all before you pour your first cup of coffee. R&D Director of Quality Assistance talks about how Waters’ new LC-MS system allows his team to do it. Coming Jan. 22! http://bit.ly/2QZEJ8i#SmartMassSpecpic.twitter.com/FwCTatsu2i -
Our FLEXMAG 4050 C electromagnetic flowmeter features a biocompatible disposable
#flow tube specifically developed for single-use#biopharm applications.@Labcompare has the details: https://bit.ly/2Ni5p6f pic.twitter.com/kD8cM2cTGg
-
#Disposable technology has found its place in the#biopharm industry, but where does the story go from here? https://themedicinemaker.com/issues/1118/the-next-chapter-in-single-use/ …@medicine_maker -
<1% growth in Rx spend in 2017, while
#NCE approvals higher than decades.... our market-based system working!#biopharm#innovation#iambiotech https://www.iqvia.com/institute/reports/medicine-use-and-spending-in-the-us-review-of-2017-outlook-to-2022?utm_content=buffer3e31a&utm_medium=social&utm_source=twitter.com&utm_campaign=bufferjg …
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.